General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yilmaz Y et al. – Nonalcoholic fatty liver disease (NAFLD) remains a leading cause of chronic liver disease. In the context of NAFLD, the presence of nonalcoholic steatohepatitis (NASH) portends an adverse prognosis with greater risk of liver fibrosis and cirrhosis. Although liver biopsy is the keystone of patient management in NAFLD, it is also increasingly clear that such evaluation has its limitations.

Related Articles

Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis
World Journal of Gastroenterology, 11/12/09    Relevance Score: 84%

Protective effects of SP600125 in a diet-induced model of non-alcoholic steatohepatitis
Scandinavian Journal of Gastroenterology, 11/06/09    Relevance Score: 84%

A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis: A Randomized Placebo-controlled Trial
Journal of Clinical Gastroenterology, 10/22/09    Relevance Score: 83%

Drug-Induced Steatohepatitis Leading to Cirrhosis: Long-Term Toxicity of Amiodarone Use
Seminars in Liver Disease, 10/16/09    Relevance Score: 83%

Toxicant-associated steatohepatitis in vinyl chloride workers
Hepatology, 11/11/09    Relevance Score: 82%

Today in Hepatology...keeping you current

Hyperuricemia, Gout, and Renal Function After Liver Transplantation
Transplantation, 12/18/09

No beneficial effects of amantadine in treatment of chronic hepatitis C patients
Digestive and Liver Diseases, 12/18/09

Air cavitogram as investigative modality for Amoebic Liver Abscess
The Internet Journal of Gastroenterology, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address